How does the device work?

The device screens for drug use by analysing chemicals (known as metabolites) contained in the minute traces of sweat found in a fingerprint. Metabolites are produced by the body as a result of normal metabolic processes and can be analysed to identify the substances a person has ingested, inhaled or injected. The presence of drug metabolites in someone’s fingerprint sweat indicates drug use by that individual.

What are its advantages?

Our drug screening technique is non-invasive and does not require specialist sample collection or biohazard precautions. The device is handheld and ideal for use in almost any location at any time. It provides results in less than 10 minutes and screens for multiple drugs of abuse in one cost-effective disposable test.

How easy is it to use?

The device is easy to use, requiring no special training. The fingerprint sample is obtained on a collection cartridge and the cartridge reader is touchscreen-operated and fully automated. Results are presented within ten minutes giving a simple pass/fail against pre-determined drug screening cut-off levels. The device automatically measures drug concentration against these cut-offs without the need for the operator to read test strip results or similar.

Which drugs will it detect?

Initially, the device will screen for four commonly abused groups of drugs: Amphetamine, Cannabis, Cocaine and Opiates.

How quick is the test?

The device screens for multiple drugs of abuse in less than 10 minutes.

How accurate is it?

Our technology will be as accurate as conventional point-of-care drug screening methods. The test can be calibrated to different cut-off levels, which means the pass/fail criteria can be altered to different drug levels according to customer requirements.

What is the window of detection?

Analysis of fingerprint sweat gives an indication of an individual’s recent drug use habits.

What about cross contamination?

The technique detects drug metabolites rather than the drugs themselves, so a positive result indicates that the person being screened has taken the drug and not simply touched a surface contaminated with the parent drug.

When will the device be available?

The device will be launching soon. Register online for our e-newsletter if you would like to receive updates from us.

How much will it cost?

Pricing of the reader and the sample collection cartridges will depend on customer requirements and will vary depending upon the number of tests being carried out. The overall cost of carrying out a test will compare favourably with existing drug screens of similar complexity.

Do you have regulatory approval?

Intelligent Fingerprinting has ISO 9001 and ISO 13485 certification. These certificates are available to download from the Quality section of our website. We have also shared details of our technology and testing device with the UK Home Office and they have set out requirements for Type Approval. These requirements will inform future development activities and quality assurance which we expect will lead to Home Office Type Approval at a later date.

Do you have FDA approval?

We are currently collating technical and design history files prior to seeking FDA approval for the device.

How else could the device be used?

Our fingerprint-based diagnostic technique has potential for use in many other areas such as healthcare, security and border control. Research and development is ongoing in these areas. Please contact us to discuss potential opportunities.